GBP2 has also been implicated in the prognosis of pancreatic cancer, cutaneous melanoma, and is involved in cutaneous melanoma progression through the Wnt/beta-catenin pathway (Ji et al., 2021; Liu et al., 2021). Here, CTNNB1 is linked to cutaneous melanoma.